For years, the nutrition world has been embroiled in a tug-of-war over the efficacy of low-carbohydrate diets. Proponents laud their ability to shed unwanted pounds and stabilize blood glucose, while critics point to potentially concerning spikes in low-density lipoprotein (LDL) cholesterol—the so-called "bad" cholesterol that serves as a primary biomarker for heart disease risk.
New research presented at NUTRITION 2026, the flagship annual meeting of the American Society for Nutrition, suggests that this debate may be missing a critical variable: our DNA. A team of researchers from the Stanford University School of Medicine has unveiled findings indicating that genetics play a significant, perhaps decisive, role in how an individual’s cholesterol levels respond to low-carb, high-fat nutritional strategies.
The Mystery of Dietary Heterogeneity
The clinical observation that two people can follow the exact same dietary regimen and emerge with vastly different health markers has long frustrated both patients and practitioners. In the realm of low-carbohydrate dieting, this inconsistency is particularly pronounced.
"Our findings highlight that there is real heterogeneity in how people respond to diet," says Alexa Barad, PhD, RDN, a postdoctoral scholar at Stanford University School of Medicine and lead author of the study. "Dietary conversations can sometimes become overly simplified. One person may say, ‘Low-carb diets always raise LDL cholesterol,’ while another says, ‘My LDL cholesterol did not change at all.’ Our findings suggest that both experiences can be true, depending, at least in part, on the individual’s genetic makeup."
The study posits that saturated fat—which often constitutes a larger portion of calories in low-carb diets—interacts directly with an individual’s genetic predisposition. For those with a specific genetic profile, this interaction triggers a significant rise in LDL cholesterol, potentially offsetting the metabolic benefits of carbohydrate restriction.
A Chronological Look at the DIETFITS Trial
To understand the nuance behind these results, it is necessary to look back at the foundation of this research: the DIETFITS (Diet Intervention Examining The Factors Interacting with Treatment Success) trial.
- The Baseline: The original DIETFITS study was a massive, randomized controlled trial involving more than 600 adults. For one full year, participants were assigned to either a "healthy low-carb" or "healthy low-fat" diet.
- The Initial Findings: Surprisingly, the original study concluded that there was no significant difference in weight loss outcomes between the two groups. It suggested that diet quality and adherence, rather than the specific macronutrient split, were the drivers of weight loss.
- The Genetic Pivot: Recognizing that "average" results often mask individual variations, Dr. Barad and her colleagues sought to re-examine the data. By narrowing their focus to 431 participants who had available genetic data, the team looked for correlations between genotype, saturated fat intake, diet type, and changes in LDL cholesterol over a six-month period.
This shift from studying broad, population-wide averages to examining individual genetic responses represents a major evolution in nutritional science, moving toward the era of "precision nutrition."
Supporting Data: The Power of Polygenic Scores
One of the most robust aspects of the Stanford analysis is the methodology used to interpret genetic influence. Rather than relying on individual genetic variants—which often provide an incomplete picture—the researchers utilized "polygenic scores."
A polygenic score is a composite metric that aggregates thousands of genetic variants across the entire genome to estimate an individual’s overall genetic tendency toward a specific trait—in this case, high or low LDL cholesterol.
Key Findings:
- Genetic Sensitivity: Among participants on the low-carb diet, those who possessed a higher polygenic score (indicating a genetic predisposition toward higher LDL levels) were significantly more likely to experience an increase in LDL cholesterol.
- The Saturated Fat Trigger: The researchers discovered that the rise in cholesterol was driven by the consumption of saturated fat. Participants with the highest genetic risk profile showed the most dramatic LDL spikes when their saturated fat intake was high.
- The Diet-Specific Effect: Crucially, this relationship was not observed among individuals following the low-fat diet. This suggests that the metabolic stressor is not the fat itself, but the specific interaction between a high-saturated-fat environment and the individual’s genetic susceptibility to cholesterol dysregulation.
Expert Perspectives and Clinical Implications
The implications of this research are profound for the field of personalized medicine. Dr. Barad emphasizes that while the study provides groundbreaking insight, it does not mean that low-carb diets are inherently "bad." Rather, it suggests that the "one-size-fits-all" approach to dietary advice is becoming obsolete.
"Our findings suggest that some individuals may be more sensitive to the LDL cholesterol-raising effects of saturated fat, particularly in the context of a low-carbohydrate diet, because of their genetic background," Dr. Barad explained.
The study acts as a clarion call for clinicians to shift away from dogmatic dietary prescriptions. If a patient is considering a low-carb approach to manage blood sugar or weight, the study suggests that a baseline lipid panel and ongoing monitoring are essential. If that patient happens to be genetically predisposed to higher cholesterol, a low-carb diet high in butter, fatty meats, and processed lard might be ill-advised, whereas a low-carb diet rich in plant-based unsaturated fats could yield safer outcomes.
Practical Guidance: Beyond Genetic Testing
While the use of polygenic scores is currently a research tool, Dr. Barad notes that patients do not need expensive genetic testing to make informed decisions today. The practical takeaway is the importance of individual monitoring.
"Monitoring cholesterol may matter more than following one rule," Barad notes. "It is important to monitor how an individual’s body responds rather than assuming a particular diet will produce the same results for everyone."
Recommendations for the Low-Carb Dieter:
For those committed to a low-carbohydrate lifestyle, the researchers suggest a "heart-healthy" shift in fat sources:
- Prioritize Unsaturated Fats: Emphasize sources such as nuts, seeds, olive oil, and avocado. These fats are generally associated with better cardiovascular profiles compared to saturated animal fats.
- Limit Saturated Fat Sources: Reduce the intake of butter, beef tallow, fatty cuts of meat, and processed meats, which may exacerbate LDL increases in susceptible individuals.
- Routine Testing: Anyone embarking on a significant dietary change should work with a healthcare provider to track lipid panels at three- and six-month intervals to ensure the diet is not negatively impacting heart health biomarkers.
Future Directions and Limitations
As with all research presented at major conferences, these findings are considered preliminary until they undergo the rigorous peer-review process required for publication in a scientific journal. The researchers acknowledge that further study is needed to confirm these results across a more diverse demographic, as the DIETFITS trial may not be representative of all ethnic or socioeconomic populations.
Additionally, the study highlights a need for more research into the "how" and "why" of these genetic interactions. Understanding the specific biological mechanisms by which certain genotypes process saturated fat could eventually lead to targeted nutritional therapies.
For now, the Stanford study serves as a necessary reminder that nutrition is a biological conversation between the food we eat and the genes we inherit. As we look toward the future of health, it is increasingly clear that the most effective diet is not the one that works for the most people, but the one that is optimized for the individual.
The DIETFITS trial was funded by grant 1R01DK091831 from the National Institute of Diabetes and Digestive and Kidney Diseases; grants 1K12GM088033 and T32HL007034 from the National Heart, Lung, and Blood Institute; and the Stanford Clinical and Translational Science Award, grant UL1TR001085 from the National Institutes of Health. Dr. Alexa Barad was supported by the American Heart Association Postdoctoral Fellowship (26POST1542318). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders.
